Liberty Wealth Management LLC Biogen Inc. Transaction History

Liberty Wealth Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$223.92 - $287.77 $114,423 - $147,050	-511 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $45.7 Million - $73.2 Million	-176,433 Reduced 99.71%	511 $177,000
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $45.7 Million - $73.2 Million	176,433 Added 34527.01%	176,944 $511,000
Q2 2020 Aug 04, 2020	SELL	$258.66 - $342.55 $25,348 - $33,569	-98 Reduced 16.09%	511 $137,000
Q1 2020 Apr 27, 2020	BUY	$268.85 - $341.04 $4,032 - $5,115	15 Added 2.53%	609 $193,000
Q4 2019 Feb 05, 2020	BUY	$220.06 - $304.07 $98,586 - $136,223	448 Added 306.85%	594 $176,000
Q3 2019 Oct 30, 2019	SELL	$217.44 - $243.88 $98,065 - $109,989	-451 Reduced 75.54%	146 $34,000
Q2 2019 Jul 30, 2019	BUY	$219.29 - $241.72 $78,505 - $86,535	358 Added 149.79%	597 $140,000
Q1 2019 Apr 18, 2019	BUY	$216.71 - $338.96 $8,668 - $13,558	40 Added 20.1%	239 $56,000
Q4 2018 Mar 26, 2019	BUY	$278.5 - $352.75 $55,421 - $70,197	199 New	199 $59,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Liberty Wealth Management LLC with notifications on news.